Alzheimer's Association International Conference

Following hot on the heels of yesterday’s announcement that Eli-Lilly’s drug solanezumab heralded a breakthrough in the treatment of Alzheimer’s, the EPM team has done some digging and presents four additional newsworthy developments in the field. more


The posters will highlight recent cell and animal studies showing that a compound selected by Oligomerix's proprietary technology platform can reduce pathological tau aggregates. more